Ann: FDA Clears PYC to Commence First Human Trials in RP11, page-77

alternatively delivery/execution of a sub-milestone every fortnight worth reporting on might give the dopamine fix the market needs to maintain momentum

- HREC approval
- first patient recruited
- first patient dosed
- ADOA / PYC-001 lead selected with enhanced v2 delivery/exon skipping profile

the above to follow on from the Mar 6th announcement will keep the momentum going.

Not asking for hype, but steady timely progress updates will help investors understand when they click on our ticket and glance at our ASX announcement headers. Will be great if they tune into our investor call, but that’s a dime a dozen.